| 1 |
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations.Nat Genet. 2014 May;46(5):451-6. doi: 10.1038/ng.2936. Epub 2014 Apr 6.
|
| 2 |
Bmi-1 promotes glioma angiogenesis by activating NF-B signaling.PLoS One. 2013;8(1):e55527. doi: 10.1371/journal.pone.0055527. Epub 2013 Jan 31.
|
| 3 |
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas.Nat Genet. 2013 Jun;45(6):602-12. doi: 10.1038/ng.2611. Epub 2013 Apr 14.
|
| 4 |
Targeting X box-binding protein-1 (XBP1) enhances sensitivity of glioma cells to oxidative stress.Neuropathol Appl Neurobiol. 2011 Jun;37(4):395-405. doi: 10.1111/j.1365-2990.2010.01155.x.
|
| 5 |
Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.Cancer Immunol Immunother. 2008 Jan;57(1):123-31. doi: 10.1007/s00262-007-0336-x. Epub 2007 May 24.
|
| 6 |
Genome-wide association study identifies five susceptibility loci for glioma.Nat Genet. 2009 Aug;41(8):899-904. doi: 10.1038/ng.407. Epub 2009 Jul 5.
|
| 7 |
Expression of voltage-gated chloride channels in human glioma cells.J Neurosci. 2003 Jul 2;23(13):5572-82. doi: 10.1523/JNEUROSCI.23-13-05572.2003.
|
| 8 |
Promoter hypermethylation is not the major mechanism for inactivation of the FBXW7 beta-form in human gliomas.Genes Genet Syst. 2008 Aug;83(4):347-52. doi: 10.1266/ggs.83.347.
|
| 9 |
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas.J Clin Oncol. 2000 Feb;18(4):708-15. doi: 10.1200/JCO.2000.18.4.708.
|
| 10 |
Heavy chain ferritin siRNA delivered by cationic liposomes increases sensitivity of cancer cells to chemotherapeutic agents.Cancer Res. 2011 Mar 15;71(6):2240-9. doi: 10.1158/0008-5472.CAN-10-1375. Epub 2011 Mar 8.
|
| 11 |
Human alloreactive CTL interactions with gliomas and with those having upregulated HLA expression from exogenous IFN-gamma or IFN-gamma gene modification.J Interferon Cytokine Res. 2003 Jul;23(7):379-93. doi: 10.1089/107999003322226032.
|
| 12 |
A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma.Anticancer Drugs. 2008 Feb;19(2):133-42. doi: 10.1097/CAD.0b013e3282f24017.
|
| 13 |
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.J Clin Oncol. 2009 Dec 10;27(35):5874-80. doi: 10.1200/JCO.2009.23.6497. Epub 2009 Nov 9.
|
| 14 |
MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism.Nat Genet. 2016 Mar;48(3):273-82. doi: 10.1038/ng.3500. Epub 2016 Feb 1.
|
| 15 |
Glioma migration can be blocked by nontoxic inhibitors of myosin II.Cancer Res. 1999 May 1;59(9):2076-82.
|
| 16 |
The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma.Nat Genet. 2014 May;46(5):444-450. doi: 10.1038/ng.2938. Epub 2014 Apr 6.
|
| 17 |
Clinicopathological significance of Polo-like kinase 1 (PLK1) expression in human malignant glioma.Acta Histochem. 2012 Sep;114(5):503-9. doi: 10.1016/j.acthis.2011.09.004. Epub 2011 Oct 13.
|
| 18 |
The rat sodium iodide symporter gene permits more effective radioisotope concentration than the human sodium iodide symporter gene in human and rodent cancer cells.Cancer Gene Ther. 2003 Jan;10(1):14-22. doi: 10.1038/sj.cgt.7700525.
|
| 19 |
Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth.Cancer Res. 2002 Feb 15;62(4):1205-12.
|
| 20 |
Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea.Am J Pathol. 2006 May;168(5):1676-85. doi: 10.2353/ajpath.2006.050400.
|
| 21 |
The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer.Clin Immunol. 2006 Nov;121(2):144-58. doi: 10.1016/j.clim.2006.06.010. Epub 2006 Aug 10.
|
| 22 |
Possible novel therapy for malignant gliomas with secretable trimeric TRAIL.PLoS One. 2009;4(2):e4545. doi: 10.1371/journal.pone.0004545. Epub 2009 Feb 20.
|
| 23 |
DNA topoisomerase II-alpha as a proliferation marker in human gliomas: correlation with PCNA expression and patient survival.Clin Neuropathol. 2008 Mar-Apr;27(2):83-90. doi: 10.5414/npp27083.
|
| 24 |
Glial cell-line derived neurotrophic factor (GDNF) family of ligands confer chemoresistance in a ligand-specific fashion in malignant gliomas. J Clin Neurosci. 2009 Mar;16(3):427-36. doi: 10.1016/j.jocn.2008.06.002. Epub 2009 Jan 12.
|
| 25 |
In vitro drug response and molecular markers associated with drug resistance in malignant gliomas. Clin Cancer Res. 2006 Aug 1;12(15):4523-32. doi: 10.1158/1078-0432.CCR-05-1830.
|
| 26 |
Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.Oncotarget. 2017 Feb 28;8(9):15071-15084. doi: 10.18632/oncotarget.14748.
|
| 27 |
Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action. Cell Death Differ. 2011 Jun;18(6):959-73. doi: 10.1038/cdd.2010.170. Epub 2011 Jan 14.
|
| 28 |
Epigenetic regulation of c-ROS receptor tyrosine kinase expression in malignant gliomas. Cancer Res. 2009 Mar 15;69(6):2180-4. doi: 10.1158/0008-5472.CAN-08-3351. Epub 2009 Mar 10.
|
| 29 |
The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas. J Natl Cancer Inst. 2007 Apr 18;99(8):639-52. doi: 10.1093/jnci/djk135.
|
| 30 |
Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas.Nat Genet. 2014 Jul;46(7):726-30. doi: 10.1038/ng.2995. Epub 2014 Jun 1.
|
| 31 |
Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction.Int J Cancer. 2006 Nov 15;119(10):2330-8. doi: 10.1002/ijc.22108.
|
| 32 |
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.Nat Genet. 2009 Aug;41(8):905-8. doi: 10.1038/ng.408. Epub 2009 Jul 5.
|
| 33 |
Neonatal exposure to estradiol/bisphenol A alters promoter methylation and expression of Nsbp1 and Hpcal1 genes and transcriptional programs of Dnmt3a/b and Mbd2/4 in the rat prostate gland throughout life.Endocrinology. 2012 Jan;153(1):42-55. doi: 10.1210/en.2011-1308. Epub 2011 Nov 22.
|
| 34 |
ATDC contributes to sustaining the growth and invasion of glioma cells through regulating Wnt/-catenin signaling.Chem Biol Interact. 2019 May 25;305:148-155. doi: 10.1016/j.cbi.2019.03.033. Epub 2019 Mar 29.
|
| 35 |
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies. Nature. 2014 Oct 9;514(7521):247-51.
|
| 36 |
CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells. Int J Cancer. 2011 Mar 15;128(6):1316-26. doi: 10.1002/ijc.25466.
|
|
|
|
|
|
|
